Navigation Links
MO-SCI Corporation to manufacture, market SRNL's unique glass microspheres
Date:12/17/2009

A licensing agreement between the U.S. Department of Energy's Savannah River National Laboratory (SRNL) and specialty glass provider Mo-Sci Corporation will make SRNL's unique Porous Walled Hollow Glass Microspheres available for use in targeted drug delivery, hydrogen storage and other uses, including applications still being developed.

Hollow glass microspheres have been used for years in light-weight filler material, insulation, abrasives and other uses. What makes SRNL's patent-pending microspheres unique is the network of interconnected pores in the microsphere walls, which allow the tiny "microballoons" to be filled with, hold, and release gases and other materials. Each porous walled hollow glass microsphere is about 50 microns in diameter, about half the width of a human hair. Its walls, which are about 10,000 angstroms thick (an angstrom is one-tenth of one-billionth of a meter) feature pores that range from 100 to 300 angstroms, which allow gases to enter the tiny spheres and be stored or cycled on absorbents inside.

SRNL originally developed the unique microspheres as a solid-state storage method for hydrogen; they have been successfully demonstrated to store and release the gas.

Work since then has shown potential in other uses, including battery applications and medicine. An article by authors from the Medical College of Georgia and SRNL, which has been accepted for publication in the peer-reviewed journal Nanomedicine: Nanotechnology, Biology and Medicine, discusses a possible application for the delivery of anti-cancer drugs. (Porous-wall hollow glass microspheres as novel potential nanocarriers for biomedical applications; Shuyi Li, Lynsa Nguyen, Hairong Xiong, Meiyao Wang, Tom C.-C. Hu, Jin-Xiong She, Steven M. Serkiz, George G. Wicks, William S. Dynan; article in press)

Under the license agreement, Mo-Sci will provide SRNL with a cost-effective supply of the microspheres to continue research and development of additional applications. It also provides for aggressive marketing by Mo-Sci to be the premier supplier for medical R&D applications.


'/>"/>

Contact: Angeline French
angeline.french@srnl.doe.gov
803-725-2854
DOE/Savannah River National Laboratory
Source:Eurekalert

Related biology news :

1. GenVault Corporation to Present at the 2009 BIOCOM Investor Conference
2. GenVault Corporation to Present at the 2009 BIOCOM Investor Conference
3. Harris Corporation Adds Broadband Satellite Data Mode to JTRS-Approved Falcon III(R) AN/PRC-117G Multiband Manpack Radio
4. M2SYS Biometric Software Solution Selected By GHG Corporation
5. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
6. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
7. $29.4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation
8. delSECUR CORPORATION Announces Appointment of the Companys President & CEO
9. CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
10. Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results
11. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)...  Genos, a community for personal genetic discovery ... Laboratory Accreditation from the College of American Pathologists ... that meet stringent requirements around quality, accuracy and ... "Genos is committed to maintaining the highest ... to be receiving CAP accreditation," said Jill ...
(Date:2/13/2017)... 13, 2017  RSA Conference -- RSA, a Dell ... designed to enhance fraud detection and investigation across ... RSA Fraud & Risk Intelligence Suite. The new ... additional insights from internal and external sources as ... their customers from targeted cybercrime attacks. ...
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... Colo. , March 23, 2017  GlobeImmune, Inc. ... agreement for the sale of 12,835,490 shares of its ... NantWorks  ecosystem of companies. In connection with the sale of ... $100,000 in cash and issue to GlobeImmune 200,000 shares, ... stock. "We are pleased to enter ...
(Date:3/23/2017)... New York , March 23, 2017 ... blood plasma products and derivatives market is fragmented due to the presence ... players, such as Proliant, Thermo Fisher , and Sigma-Aldrich, compete ... leader, these three companies, collectively, held more than 76% of this ... ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... up human tissue regeneration from small lab samples to full-size tissues, bones, even ... to establish a vascular system that delivers blood deep into the developing tissue. ...
(Date:3/22/2017)... 2017   iSpecimen ®, the marketplace ... Pathology Service (DPS), a full-service anatomic pathology reference ... United States , has joined a program offered ... (DHIN) to make human biospecimens and associated data ... program, announced in 2015 as a collaboration between iSpecimen ...
Breaking Biology Technology: